BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 35392955)

  • 1. Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives.
    Marcacci M; Ricci A; Cuoghi C; Marchini S; Pietrangelo A; Ventura P
    Orphanet J Rare Dis; 2022 Apr; 17(1):160. PubMed ID: 35392955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
    Wang B; Bonkovsky HL; Lim JK; Balwani M
    Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study.
    Wang B; Ventura P; Takase KI; Thapar M; Cassiman D; Kubisch I; Liu S; Sweetser MT; Balwani M
    Orphanet J Rare Dis; 2022 Aug; 17(1):327. PubMed ID: 36028858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Givosiran for the treatment of acute hepatic porphyria.
    Ricci A; Ventura P
    Expert Rev Clin Pharmacol; 2022 Apr; 15(4):383-393. PubMed ID: 35531651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAi therapy with givosiran significantly reduces attack rates in acute intermittent porphyria.
    Sardh E; Harper P
    J Intern Med; 2022 May; 291(5):593-610. PubMed ID: 35067977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurology of the acute hepatic porphyrias.
    Oliveira Santos M; Leal Rato M
    J Neurol Sci; 2021 Sep; 428():117605. PubMed ID: 34375916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute hepatic porphyrias].
    Sayk F; Grasshoff L
    Med Klin Intensivmed Notfmed; 2023 Feb; 118(1):21-29. PubMed ID: 36598516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of acute attacks, chronic symptoms, and long-term complications among patients with acute hepatic porphyria in Japan: a real-world claims database study.
    Horie Y; Yasuoka Y; Adachi T
    Orphanet J Rare Dis; 2023 Dec; 18(1):384. PubMed ID: 38066651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Givosiran: A Review in Acute Hepatic Porphyria.
    Syed YY
    Drugs; 2021 May; 81(7):841-848. PubMed ID: 33871817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute porphyrias - A neurological perspective.
    Gerischer LM; Scheibe F; Nümann A; Köhnlein M; Stölzel U; Meisel A
    Brain Behav; 2021 Nov; 11(11):e2389. PubMed ID: 34661997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs).
    Bonkovsky HL; Dixon N; Rudnick S
    Mol Genet Metab; 2019 Nov; 128(3):213-218. PubMed ID: 30987916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-based discussion of the acute hepatic porphyrias: Updates on pathogenesis, diagnosis and management.
    Balwani M; Keel S; Meissner P; Sonderup M; Stein P; Yasuda M
    Liver Int; 2024 Apr; ():. PubMed ID: 38618923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurovisceral porphyrias: what a hematologist needs to know.
    Bonkovsky HL
    Hematology Am Soc Hematol Educ Program; 2005; ():24-30. PubMed ID: 16304355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy.
    Majeed CN; Ma CD; Xiao T; Rudnick S; Bonkovsky HL
    Drug Des Devel Ther; 2022; 16():1827-1845. PubMed ID: 35734365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Perspective on Acute Hepatic Porphyria with Sporadic Attacks: A Chronic Disease with Substantial Health-Related Quality of Life Impacts.
    Wheeden K; Lyon Howe D; Burrell S; Gill L; Chamberlayne J; Williams ER; Simon A; Ko JJ; Mora J; Wells T; Evans C; Paulich M; Meninger S; Lombardelli S
    Adv Ther; 2022 Sep; 39(9):4330-4345. PubMed ID: 35907153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Aminolevulinate dehydratase porphyria: Update on hepatic 5-aminolevulinic acid synthase induction and long-term response to hemin.
    Lahiji AP; Anderson KE; Chan A; Simon A; Desnick RJ; Ramanujam VMS
    Mol Genet Metab; 2020 Dec; 131(4):418-423. PubMed ID: 33199206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anesthesia in patients with acute porphyria].
    Lederer D; Weigand MA; Larmann J
    Anaesthesist; 2022 Apr; 71(4):321-330. PubMed ID: 35352131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietic and hepatic porphyrias.
    Gross U; Hoffmann GF; Doss MO
    J Inherit Metab Dis; 2000 Nov; 23(7):641-61. PubMed ID: 11117426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel treatment options for acute hepatic porphyrias.
    Wang B
    Curr Opin Gastroenterol; 2021 May; 37(3):194-199. PubMed ID: 33769375
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.